Diabetic Macular Edema (DME) Recruiting Phase 3 Trials for Ranibizumab (DB01270)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04063358Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract SurgeryTreatment
NCT04108156This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal RanibizumabTreatment